---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-025483"
form_type: "8-K"
ticker: "CRDF"
cik: "0001213037"
company_name: "Cardiff Oncology, Inc."
filed_at: "2023-07-24T23:59:59+00:00"
generated_at: "2026-06-13T04:03:00.256957+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Cardiff Oncology grants 50,016 stock options to new employee as inducement

## Summary
- Grant of non-qualified stock options for 50,016 shares at $1.49 per share.
- Options vest over 4 years: 25% after 1 year, then monthly for 36 months.
- Grant made as inducement material to new employee's hiring under Nasdaq Rule 5635(c)(4).
- One new employee received the award on July 24, 2023.

## SEC filing metadata
- accession: 0001628280-23-025483
- form_type: 8-K
- ticker: CRDF
- cik: 0001213037
- company_name: Cardiff Oncology, Inc.
- filed_at: 2023-07-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1213037/000162828023025483/0001628280-23-025483-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1213037/000162828023025483/crdf-20230724.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-025483
- JSON: https://secwatch.observer/filing/0001628280-23-025483.json
- Plain text: https://secwatch.observer/filing/0001628280-23-025483.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.